-
1
-
-
0030088953
-
Treatment of Helicobacter pylori infection: A review of the world literature
-
1. van der Hulst RWM, Keller JJ, Rauws EAJ, et al. Treatment of Helicobacter pylori infection: A review of the world literature. Helicobacter 1996;1:6-19.
-
(1996)
Helicobacter
, vol.1
, pp. 6-19
-
-
Van Der Hulst, R.W.M.1
Keller, J.J.2
Rauws, E.A.J.3
-
2
-
-
0029979323
-
Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain)
-
2. Tefera S, Berstad A, Bang CJ, et al. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain). Am J Gastroenterol 1996;91:935-41.
-
(1996)
Am J Gastroenterol
, vol.91
, pp. 935-941
-
-
Tefera, S.1
Berstad, A.2
Bang, C.J.3
-
3
-
-
0030604372
-
Consensus statement: Medical treatment of peptic ulcer disease
-
3. The American College of Gastroenterology. Consensus statement: Medical treatment of peptic ulcer disease (practice guidelines). JAMA 1996;275:622-9.
-
(1996)
JAMA
, vol.275
, pp. 622-629
-
-
-
4
-
-
0030067239
-
Triple therapy vs. Amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: A multicenter, prospective, randomized, controlled study of efficacy and side effects
-
4. Thijs JC, van Zwet AA, Moolenaar W, et al. Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: A multicenter, prospective, randomized, controlled study of efficacy and side effects. Am J Gastroenterol 1996;91:93-7.
-
(1996)
Am J Gastroenterol
, vol.91
, pp. 93-97
-
-
Thijs, J.C.1
Van Zwet, A.A.2
Moolenaar, W.3
-
5
-
-
0028111558
-
10 Days of triple treatment of Helicobacter pylori infection and peptic ulcer. Status after treatment of 4 weeks and of one year
-
5. Berstad A, Berstad K, Hatlebakk JG, et al. 10 days of triple treatment of Helicobacter pylori infection and peptic ulcer. Status after treatment of 4 weeks and of one year. Tidsskr Nor Laegeforen 1994;114:2477-9.
-
(1994)
Tidsskr Nor Laegeforen
, vol.114
, pp. 2477-2479
-
-
Berstad, A.1
Berstad, K.2
Hatlebakk, J.G.3
-
6
-
-
0026521918
-
Factors influencing the eradication of Helicobacter pylori with triple therapy
-
6. Grahams DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992;102:493-6.
-
(1992)
Gastroenterology
, vol.102
, pp. 493-496
-
-
Grahams, D.Y.1
Lew, G.M.2
Malaty, H.M.3
-
7
-
-
0029020465
-
The best therapy for Helicobacter pylori infection: Should efficacy or side-effect profile determine our choice?
-
7. de Boer WA, Tytgat GN. The best therapy for Helicobacter pylori infection: Should efficacy or side-effect profile determine our choice? Scand J Gastroenterol 1995;30:401-7.
-
(1995)
Scand J Gastroenterol
, vol.30
, pp. 401-407
-
-
De Boer, W.A.1
Tytgat, G.N.2
-
8
-
-
0029901103
-
How to treat Helicobacter pylori infection - Should treatment strategies be based on testing bacterial susceptibility? a personal viewpoint
-
8. de Boer WA, Tytgat GNJ. How to treat Helicobacter pylori infection - should treatment strategies be based on testing bacterial susceptibility? A personal viewpoint (review). Eur J Gastroenterol Hepatol 1996;8:709-16.
-
(1996)
Eur J Gastroenterol Hepatol
, vol.8
, pp. 709-716
-
-
De Boer, W.A.1
Tytgat, G.N.J.2
-
9
-
-
0030891435
-
A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: A prospective randomized 1-yr follow-up study
-
9. Lerang F, Moum B, Ragnhildstveit E, et al. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: A prospective randomized 1-yr follow-up study. Am J Gastroenterol 1997;92:653-8.
-
(1997)
Am J Gastroenterol
, vol.92
, pp. 653-658
-
-
Lerang, F.1
Moum, B.2
Ragnhildstveit, E.3
-
10
-
-
0030223132
-
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH 1 study
-
10. Lind T, Veldhuyzen van Zanten S, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH 1 study. Helicobacter 1996;1:138-44.
-
(1996)
Helicobacter
, vol.1
, pp. 138-144
-
-
Lind, T.1
Veldhuyzen Van Zanten, S.2
Unge, P.3
-
12
-
-
0028898507
-
1-Week low-dose triple therapy: New standards for Helicobacter pylori treatment
-
12. Goddard A, Logan R. 1-week low-dose triple therapy: New standards for Helicobacter pylori treatment. Eur J Gastroenterol Hepatol 1995; 7:1-3.
-
(1995)
Eur J Gastroenterol Hepatol
, vol.7
, pp. 1-3
-
-
Goddard, A.1
Logan, R.2
-
13
-
-
0031031362
-
Current European concepts in the management of Helicobacter pylori infection - The Maastricht consensus report
-
13. Malfertheiner P, Megraud F, O'Morain C, et al. Current European concepts in the management of Helicobacter pylori infection - the Maastricht Consensus Report. Eur J Gastroenterol Hepatol 1997;9:1-2.
-
(1997)
Eur J Gastroenterol Hepatol
, vol.9
, pp. 1-2
-
-
Malfertheiner, P.1
Megraud, F.2
O'Morain, C.3
-
14
-
-
0025907230
-
Diagnostic efficiency of an ultrarapid endoscopy room test for Helicobacter pylori
-
14. Thillainayagam AV, Arvind AS, Cook RS, et al. Diagnostic efficiency of an ultrarapid endoscopy room test for Helicobacter pylori. Gut 1991;32:467-9.
-
(1991)
Gut
, vol.32
, pp. 467-469
-
-
Thillainayagam, A.V.1
Arvind, A.S.2
Cook, R.S.3
-
16
-
-
0028788903
-
A simple, rapid, and highly reliable capsule-based 14C urea breath test for diagnosis of Helicobacter pylori infection
-
16. Hamlet AK, Erlandsson KI, Olbe L, et al . A simple, rapid, and highly reliable capsule-based 14C urea breath test for diagnosis of Helicobacter pylori infection. Scand J Gastroenterol 1995;30:1058-63.
-
(1995)
Scand J Gastroenterol
, vol.30
, pp. 1058-1063
-
-
Hamlet, A.K.1
Erlandsson, K.I.2
Olbe, L.3
-
17
-
-
0026577576
-
Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori
-
17. Kosunen T, Seppala K, Sarna S, et al. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992;339:893-5.
-
(1992)
Lancet
, vol.339
, pp. 893-895
-
-
Kosunen, T.1
Seppala, K.2
Sarna, S.3
-
18
-
-
0027301348
-
Kinetics of specific IgG antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy
-
18. Hirschl AM, Branstatter G, Dragosics B, et al. Kinetics of specific IgG antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy. J Infect Dis 1993;168:763-6.
-
(1993)
J Infect Dis
, vol.168
, pp. 763-766
-
-
Hirschl, A.M.1
Branstatter, G.2
Dragosics, B.3
-
20
-
-
0029840245
-
Helicobacter pylori eradication in clinical practice: One-week low-dose triple therapy is preferable to classical bismuth based triple therapy
-
20. Goddard AF, Spiller RC. Helicobacter pylori eradication in clinical practice: One-week low-dose triple therapy is preferable to classical bismuth based triple therapy. Aliment Pharmacol Ther 1996;10:1009-13.
-
(1996)
Aliment Pharmacol Ther
, vol.10
, pp. 1009-1013
-
-
Goddard, A.F.1
Spiller, R.C.2
-
21
-
-
0029949471
-
Choosing the best anti-Helicobacter pylori therapy: Effect of antimicrobial resistance
-
21. Graham DY, de Boer WA, Tytgat GN. Choosing the best anti-Helicobacter pylori therapy: Effect of antimicrobial resistance. Am J Gastroenterol 1996;91:1072-6.
-
(1996)
Am J Gastroenterol
, vol.91
, pp. 1072-1076
-
-
Graham, D.Y.1
De Boer, W.A.2
Tytgat, G.N.3
-
22
-
-
0029775120
-
Metronidazole-resistant H. pylori - of questionable clinical importance
-
22. Walt RP. Metronidazole-resistant H. pylori - of questionable clinical importance. Lancet 1996;348:489-90.
-
(1996)
Lancet
, vol.348
, pp. 489-490
-
-
Walt, R.P.1
-
23
-
-
0031467306
-
Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy
-
23. Lerang F, Moum B, Haug JB, et al. Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy. Scand J Gastroenterol 1997;32:1209-14.
-
(1997)
Scand J Gastroenterol
, vol.32
, pp. 1209-1214
-
-
Lerang, F.1
Moum, B.2
Haug, J.B.3
-
24
-
-
0002972216
-
Effects of antibiotic resistance on clarithromycin-combined triple therapy for Helicobacter pylori
-
24. Xia H, Buckley M, Hyde D, et al. Effects of antibiotic resistance on clarithromycin-combined triple therapy for Helicobacter pylori. Gut 1995;37(suppl 2):A55.
-
(1995)
Gut
, vol.37
, Issue.SUPPL. 2
-
-
Xia, H.1
Buckley, M.2
Hyde, D.3
-
25
-
-
0029850832
-
One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: Differing efficacy in previously treated and untreated patients
-
25. Moshkowitz M, Konikoff FM, Peled Y, et al. One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: Differing efficacy in previously treated and untreated patients. Aliment Pharmacol Ther 1996;10:1015-9.
-
(1996)
Aliment Pharmacol Ther
, vol.10
, pp. 1015-1019
-
-
Moshkowitz, M.1
Konikoff, F.M.2
Peled, Y.3
-
26
-
-
0002602020
-
High cure rate of H. pylori infection by one-week therapy with omeprazole, metronidazole and clarithromycin despite a negative impact by metronidazole resistance
-
26. Peitz U, Nusch A, Tillenburg B, et al. High cure rate of H. pylori infection by one-week therapy with omeprazole, metronidazole and clarithromycin despite a negative impact by metronidazole resistance. Gut 1996;39(suppl 2):A5.
-
(1996)
Gut
, vol.39
, Issue.SUPPL. 2
-
-
Peitz, U.1
Nusch, A.2
Tillenburg, B.3
-
27
-
-
0029091042
-
Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori
-
27. Moayyedi P, Sahay P, Tompkins DS, et al. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995;7:835-40.
-
(1995)
Eur J Gastroenterol Hepatol
, vol.7
, pp. 835-840
-
-
Moayyedi, P.1
Sahay, P.2
Tompkins, D.S.3
|